×
News Home

Is Nabriva Therapeutics PLC - ADR (NBRV) Stock a Great Value?

Thursday, December 03, 2020 09:49 AM | InvestorsObserver Analysts
Is Nabriva Therapeutics PLC - ADR (NBRV) Stock a Great Value?

Nabriva Therapeutics PLC - ADR (NBRV) stock is higher by 95.36% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives NBRV stock a score of 34 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 1. NBRV's rank also includes a long-term technical score of 1. The fundamental score for NBRV is 99. In addition to the average rating from Wall Street analysts, NBRV stock has a mean target price of 2. This means analysts expect the stock to fall 47.23% over the next 12 months.

Overall Score - 34
NBRV has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on NBRV!

What's Happening with NBRV Stock Today

Nabriva Therapeutics PLC - ADR (NBRV) stock has fallen -3.88% while the S&P 500 is higher by 0.08% as of 9:47 AM on Thursday, Dec 3. NBRV is lower by -$0.15 from the previous closing price of $3.94 on volume of 60,273 shares. Over the past year the S&P 500 is up 17.96% while NBRV is higher by 95.36%. NBRV lost -$0.76 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Nabriva Therapeutics PLC - ADR (NBRV) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App